Kuros Biosciences AG (LON:0RHR)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	752	710	120	48	51	55
Market Cap Growth	927.77%	493.74%	148.06%	-5.72%	-6.74%	27.87%
Enterprise Value	737	699	107	31	31	44
Last Close Price	19.74	18.92	3.25	1.35	1.62	1.71
PS Ratio	11.28	10.66	3.82	2.99	4.57	16.40
PB Ratio	14.51	13.71	2.26	0.78	0.82	0.78
P/TBV Ratio	35.05	33.12	8.15	2.67	3.01	2.45
P/FCF Ratio	416.92	393.96	-	-	-	-
P/OCF Ratio	271.53	256.57	-	-	-	-
EV/Sales Ratio	10.74	10.50	3.41	1.90	2.77	13.27
EV/EBITDA Ratio	298.38	385.86	-	-	-	-
EV/EBIT Ratio	-	7414.24	-	-	-	-
EV/FCF Ratio	408.74	387.93	-	-	-	-
Debt / Equity Ratio	0.03	0.03	0.04	0.03	0.03	0.03
Debt / EBITDA Ratio	0.66	0.66	-	-	-	-
Debt / FCF Ratio	0.88	0.88	-	-	-	-
Asset Turnover	0.97	0.97	0.44	0.21	0.15	0.04
Inventory Turnover	1.18	1.18	1.27	1.47	2.33	1.96
Quick Ratio	1.64	1.64	2.22	2.20	2.72	7.69
Current Ratio	2.14	2.14	2.77	2.49	2.91	8.76
Return on Equity (ROE)	-6.44%	-6.44%	-16.18%	-20.02%	-9.33%	-14.18%
Return on Assets (ROA)	0.09%	0.09%	-4.12%	-7.06%	-5.90%	-8.09%
Return on Capital (ROIC)	0.11%	0.11%	-4.90%	-8.21%	-6.59%	-8.81%
Return on Capital Employed (ROCE)	0.20%	0.20%	-	-	-	-
Earnings Yield	-0.50%	-0.53%	-10.70%	-27.17%	-11.95%	-17.39%
FCF Yield	0.24%	0.25%	-7.14%	-14.41%	-9.13%	-14.04%
Buyback Yield / Dilution	-3.76%	-1.69%	-7.91%	-3.37%	-34.86%	-53.69%

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.